{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:19:04Z","timestamp":1792423144901,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jsat.2020.108031","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:06:14Z","timestamp":1589155574000},"page":"108031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["One year of methadone maintenance treatment in a fentanyl endemic area: Safety, repeated exposure, retention, and remission"],"prefix":"10.1016","volume":"115","author":[{"given":"Andrew C.","family":"Stone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiah D.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Traci C.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2020.108031_bb0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jsat.2017.01.004","article-title":"Characterizing fentanyl use in methadone-maintained clients","volume":"75","author":"Arfken","year":"2017","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2020.108031_bb0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/acps.13088","article-title":"Reduction in mortality risk with opioid agonist therapy: A systematic review and meta-analysis","volume":"140","author":"Bahji","year":"2019","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.jsat.2020.108031_bb0015","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/add.14522","article-title":"What should clinicians do as fentanyl replaces heroin?","volume":"114","author":"Bisaga","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2020.108031_bb0020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.drugpo.2017.05.023","article-title":"Exposure to fentanyl- contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study","volume":"46","author":"Carroll","year":"2017","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.jsat.2020.108031_bb0030","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2105\/AJPH.2018.304666","article-title":"The first comprehensive program for opioid use disorder in a US statewide correctional system","volume":"108","author":"Clarke","year":"2018","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2020.108031_bb0035","doi-asserted-by":"crossref","DOI":"10.1111\/j.1360-0443.2006.01714.x","article-title":"Methadone maintenance treatment: The balance between life-saving treatment and fatal poisonings","volume":"102","author":"Fugelstad","year":"2007","journal-title":"Addiction (Abingdon, England)"},{"key":"10.1016\/j.jsat.2020.108031_bb0040","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jamapsychiatry.2017.4614","article-title":"Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system","volume":"75","author":"Green","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jsat.2020.108031_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.06.017","article-title":"Fentanyl exposure and preferences among individuals starting treatment for opioid use disorder","volume":"204","author":"Gryczynski","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2020.108031_bb0050","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/npp.2015.201","article-title":"Ethanol reversal of tolerance to the respiratory depressant effects of morphine","volume":"41","author":"Hill","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jsat.2020.108031_bb0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jsat.2018.01.005","article-title":"Expected and actual fentanyl exposure among persons seeking opioid withdrawal management","volume":"86","author":"Kenney","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2020.108031_bb0065","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2020.108031_bb0070","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.2105\/AJPH.2017.304007","article-title":"Development of a statewide, publicly accessible drug overdose surveillance and information system","volume":"107","author":"Marshall","year":"2017","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2020.108031_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002209.pub2","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2020.108031_bb0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2019.02.031","article-title":"Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort","volume":"200","author":"Morgan","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2020.108031_bb0085","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/dar.12418","article-title":"Opioid agonist doses for oxycodone and morphine dependence: Findings from a retrospective case series","author":"Nielsen","year":"2017","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.jsat.2020.108031_bb0090","first-page":"CD011117","article-title":"Opioid agonist treatment for pharmaceutical opioid dependent people","author":"Nielsen","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2020.108031_bb0095","doi-asserted-by":"crossref","first-page":"767","DOI":"10.15585\/mmwr.mm6727a4","article-title":"Notes from the field: Overdose deaths with carfentanil and other fentanyl analogs detected\u201410 states, July 2016\u2013June 2017","volume":"67","author":"O\u2019Donnell","year":"2018","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.jsat.2020.108031_bb0100","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.15585\/mmwr.mm6643e1","article-title":"Deaths involving fentanyl, fentanyl analogs, and U-47700-10 states, July\u2013December 2016","volume":"66","author":"O\u2019Donnell","year":"2017","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"December","key":"10.1016\/j.jsat.2020.108031_bb0105","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.abrep.2017.09.001","article-title":"Characteristics of adherence to methadone maintenance treatment over a 15-year period among homeless adults","volume":"6","author":"Parpouchi","year":"2017","journal-title":"Addictive Behaviors Reports"},{"key":"10.1016\/j.jsat.2020.108031_bb0110","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths\u2014United States, 2000\u20132014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"4","key":"10.1016\/j.jsat.2020.108031_bb0115","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1037\/0893-164X.11.4.294","article-title":"Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS)","volume":"11","author":"Simpson","year":"1997","journal-title":"Psychology of Addictive Behaviors"},{"issue":"14","key":"10.1016\/j.jsat.2020.108031_bb0120","doi-asserted-by":"crossref","first-page":"382","DOI":"10.15585\/mmwr.mm6614a2","article-title":"Characteristics of fentanyl overdose\u2014Massachusetts, 2014\u20132016","volume":"66","author":"Somerville","year":"2017","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.jsat.2020.108031_bb0125","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jsat.2020.108031_bb0130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.drugalcdep.2018.07.019","article-title":"Methadone maintenance treatment among patients exposed to illicit fentanyl in Rhode Island: Safety, dose, retention, and relapse at 6 months","volume":"192","author":"Stone","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2020.108031_bb0135","series-title":"2018 national drug threat assessment","author":"U.S. Drug Enforcement Agency (DEA)","year":"2018"},{"key":"10.1016\/j.jsat.2020.108031_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ADM.0000000000000275","article-title":"Medications for addiction treatment: Changing language to improve care","volume":"11","author":"Wakeman","year":"2017","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2020.108031_bb0145","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/ADM.0000000000000486","article-title":"Impact of fentanyl use on buprenorphine treatment retention and opioid abstinence","volume":"13","author":"Wakeman","year":"2019","journal-title":"Journal of Addiction Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2020.108031_bb0150","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Network Open"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074054721930649X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074054721930649X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:51:27Z","timestamp":1760039487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074054721930649X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":28,"alternative-id":["S074054721930649X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2020.108031","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"One year of methadone maintenance treatment in a fentanyl endemic area: Safety, repeated exposure, retention, and remission","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2020.108031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108031"}}